Loading organizations...
Loading organizations...
Biotech company developing therapies for neuro-inflammatory diseases.
Xalud Therapeutics has raised $30.0M across 1 funding round.
Xalud Therapeutics has raised $30.0M in total across 1 funding round.
Xalud Therapeutics has raised $30.0M in total across 1 funding round.
Xalud Therapeutics's investors include Sean Stalfort.
Xalud Therapeutics has raised $30.0M across 1 funding round. Most recently, it raised $30.0M Series C in August 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 24, 2021 | $30.0M Series C | Sean Stalfort |